Annual Report to shareholders

Notice of Annual General Meeting/Proxy Form

Response to Price and Volume Query

Company Presentation – October 2024

Notification of cessation of securities – AYA

Issue of Shares on RSU Exercise and Cleansing Notice

Application for quotation of securities – AYA

Artrya Submits 510(k) Application to US FDA

Appendix 4E and Annual Financial Statements June 2024

AYA on track for FDA application submission following Q-sub